Estonia Pharmaceuticals & Healthcare Q1 2021
Key View:
We hold an improved outlook for health spending in Estonia as greater resources are allocated to the healthcare systemamid the coronavirus pandemic. However, existing shortages of vital medicines will continue to impact healthcare outcomes forpatients in Estonia. The country’s drug shortages will only be made worse by the pandemic, in addition to the newly implementedpharmacy ownership reforms, as some pharmacies close due to either staff quarantining. Nonetheless, we maintain a relativelypositive long-term outlook for medicine spending growth as healthcare funding continues to increase.
- Key View
- Estonia Pharmaceuticals & Healthcare Covid-19 Impact
- SWOT
- Industry Forecast
- Pharmaceutical Market Forecast
- Healthcare Market Forecast
- Prescription Drug Market Forecast
- Patented Drug Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast
- Industry Risk/Reward Index
- Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
- Innovative Pharmaceuticals Risk/Reward Index
- Regulatory Development
- Regulatory Review
- Market Overview
- Competitive Landscape
- Company Profile
- Grindeks
- Estonia Demographic Outlook
- Pharmaceuticals & Healthcare Glossary
- Pharmaceuticals & Healthcare Methodology
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook